2,926
Views
11
CrossRef citations to date
0
Altmetric
Review

Progress in the development of virus-like particle vaccines against respiratory viruses

, , , ORCID Icon &
Pages 11-24 | Received 11 Jun 2019, Accepted 30 Dec 2019, Published online: 18 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tushar Baviskar, Dezaree Raut & Lokesh Kumar Bhatt. (2021) Deciphering Vaccines for COVID-19: where do we stand today?. Immunopharmacology and Immunotoxicology 43:1, pages 8-21.
Read now

Articles from other publishers (10)

Runnian Wang, Chun Zhang, Yao Zhang, Jiaqi Wu, Yuxiang Zhang, Luyao Zhang, Rong Yu & Yongdong Liu. (2023) Synergetic interaction of capsid proteins for virus-like particles assembly of foot-and-mouth disease virus (serotype O) from the inclusion bodies. Protein Expression and Purification 204, pages 106231.
Crossref
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines 514 551.e31 .
Ramalingam Karthik Raja, Phuong Nguyen-Tri, Govindasamy Balasubramani, Arun Alagarsamy, Selcuk Hazir, Safa Ladhari, Alireza Saidi, Arivalagan Pugazhendhi & Arulandhu Anthoni Samy. (2021) SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches. Applied Nanoscience 13:1, pages 65-93.
Crossref
Samira S. Abolmaali, Vahid Alimardani, Ghazal Farahavar, Haniyeh Najafi, Mina Shafiee, Nader Tanideh, Ali M. Tamaddon & Samad Ahadian. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance 305 364 .
Jiao Hu, Peipei Peng, Jun Li, Qi Zhang, Rumeng Li, Xiaoquan Wang, Min Gu, Zenglei Hu, Shunlin Hu, Xiaowen Liu, Xinan Jiao, Daxin Peng & Xiufan Liu. (2021) Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses. Frontiers in Veterinary Science 8.
Crossref
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta & Prabuddha Kumar Kundu. (2021) PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2. Heliyon 7:10, pages e08124.
Crossref
Francesco Citiulo, Cristina Crosatti, Luigi Cattivelli & Chiara Biselli. (2021) Frontiers in the Standardization of the Plant Platform for High Scale Production of Vaccines. Plants 10:9, pages 1828.
Crossref
Ivana Ruseska, Katja Fresacher, Christina Petschacher & Andreas Zimmer. (2021) Use of Protamine in Nanopharmaceuticals—A Review. Nanomaterials 11:6, pages 1508.
Crossref
Mohammad Ali Derakhshan, Amir Amani & Reza Faridi-Majidi. (2021) State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Applied Materials & Interfaces 13:13, pages 14816-14843.
Crossref
Ki-Back Chu & Fu-Shi Quan. 2021. Nanoparticles for Rational Vaccine Design. Nanoparticles for Rational Vaccine Design 77 106 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.